mirvetuximab
ImmunoGen
['mirvetuximab', 'ovarian']
dr. kathleen moore presenting mirvetuximab soravtansine vs. chemotherapy in platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression #asco23 
Director of Radiation Oncology, Elmhurst Hospital Center; Co-founder The Umbilicus Inc. Tweets mine